What Is Semaglutide and Why Does It Have Multiple Prices?
Semaglutide is the active pharmaceutical ingredient in three FDA-approved medications: Ozempic (weekly injection, type 2 diabetes), Wegovy (weekly injection or daily tablet, weight management), and Rybelsus (daily oral tablet, type 2 diabetes). All three are manufactured by Novo Nordisk and contain the same molecule — semaglutide — but they are approved for different indications, use different doses, and are priced differently.
Understanding semaglutide cost requires knowing which product is right for your situation, because the pricing programs, insurance coverage, and savings options differ significantly between the three branded versions.
Semaglutide Cost by Product: 2026 Overview
| Product | Form | Indication | List Price/Month | Lowest Self-Pay Price |
|---|---|---|---|---|
| Ozempic | Weekly injection | Type 2 diabetes, CV risk | ~$997 | $199 (new patients, NovoCare) |
| Wegovy | Weekly injection | Weight management | ~$1,349 | $199 (new patients, NovoCare) |
| Wegovy | Daily oral tablet | Weight management | ~$1,349 | $199 (new patients, NovoCare) |
| Rybelsus | Daily oral tablet | Type 2 diabetes | ~$850 | $10/month (with savings card + coverage) |
| Compounded semaglutide | Injection or oral | Off-label | $150–$400 | Varies by pharmacy |
The list prices above are wholesale acquisition costs. The actual price you pay depends on your insurance status, which savings program you use, and where you fill your prescription.
Ozempic Cost: The Diabetes Semaglutide
Ozempic is the most widely prescribed semaglutide product, with over 7 million prescriptions filled in the U.S. in 2025. It is approved for type 2 diabetes and cardiovascular risk reduction.
Without insurance: $997/month list price. Through the Novo Nordisk Savings Card and NovoCare Pharmacy:
- New patients: $199/month for the first 2 fills of 0.25 mg or 0.5 mg (through June 30, 2026)
- Ongoing: $349/month for 0.25–1 mg; $499/month for 2 mg
With commercial insurance coverage: As little as $25/month (savings card, up to $100/month savings).
Medicare: Covered for type 2 diabetes. Out-of-pocket costs capped at $2,100/year under the Inflation Reduction Act.
Wegovy Cost: The Weight Management Semaglutide
Wegovy is the highest-dosed semaglutide product (up to 2.4 mg injection or 25 mg oral tablet) and is specifically approved for chronic weight management. It carries the highest list price in the semaglutide family.
Without insurance: $1,349/month list price. Through NovoCare Pharmacy:
- New patients: $199/month for the first 2 fills of starter doses (through June 30, 2026)
- 1.5 mg and 4 mg doses: $149/month (4 mg offer through August 31, 2026)
With commercial insurance coverage: As little as $25/month (savings card, up to $100/month savings).
Medicare: Does not cover Wegovy for weight loss only. May cover for cardiovascular risk reduction in eligible patients.
Rybelsus Cost: The Oral Diabetes Semaglutide
Rybelsus is the original oral semaglutide tablet, approved for type 2 diabetes. It is taken once daily on an empty stomach (at least 30 minutes before food or other medications). Available in 3 mg, 7 mg, and 14 mg doses.
Without insurance: ~$850/month list price. The Novo Nordisk Savings Card provides:
- With commercial insurance coverage: As little as $10/month
- Without coverage: Reduced pricing through the savings card
Rybelsus is not approved for weight management and is not interchangeable with Wegovy tablets (which use a different formulation and dose).
Compounded Semaglutide: What Is Still Available in 2026?
Compounded semaglutide became widely available in 2023–2024 when Ozempic and Wegovy were on the FDA drug shortage list. At its peak, compounded semaglutide cost $150–$400/month — dramatically less than brand-name products.
The situation in 2026: The FDA removed semaglutide from its drug shortage list in early 2025. This means:
- 503B outsourcing facilities (the large-scale compounding pharmacies that supplied most telehealth platforms) are no longer permitted to compound semaglutide for general distribution.
- 503A compounding pharmacies (which compound for individual patients with a specific prescription) may still compound semaglutide in limited circumstances, but this pathway is narrowing and subject to FDA enforcement.
- Most major telehealth platforms (Hims & Hers, Ro, Noom Med) have transitioned from compounded to brand-name semaglutide.
Patients currently on compounded semaglutide should discuss transitioning to brand-name Ozempic or Wegovy with their prescribing provider. Given that NovoCare Pharmacy now offers Wegovy at $199/month for new patients, the price gap between compounded and brand-name semaglutide has narrowed considerably.
Semaglutide vs. Tirzepatide: Which Costs Less?
Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are the two dominant GLP-1 medication families. Here is how their costs compare for uninsured patients in 2026:
| Scenario | Semaglutide (Ozempic/Wegovy) | Tirzepatide (Mounjaro/Zepbound) |
|---|---|---|
| New patient, starter dose | $199/month (NovoCare) | $299/month (Zepbound vial, LillyDirect) |
| Ongoing, uninsured | $349–$499/month (Ozempic) | $299–$449/month (Zepbound vials) |
| With commercial insurance | $25/month | $25/month |
| Average weight loss | ~15% (Wegovy) | ~20–22% (Zepbound) |
| Diabetes efficacy | Strong | Superior (dual mechanism) |
For new uninsured patients, semaglutide's $199 introductory offer is currently cheaper than tirzepatide's $299 starting vial price. For ongoing treatment, tirzepatide vials ($299–$449/month) are often comparable or cheaper than semaglutide at maintenance doses, and tirzepatide produces greater weight loss on average.
See our full Tirzepatide Cost guide for a complete comparison.
How Insurance Coverage for Semaglutide Works
Insurance coverage for semaglutide depends on the indication:
For type 2 diabetes (Ozempic, Rybelsus): Most commercial plans cover semaglutide for diabetes. Prior authorization is typically required, and your doctor will need to document inadequate glycemic control on first-line agents (usually metformin).
For weight management (Wegovy): Coverage is improving but inconsistent. Approximately 40–50% of commercial plans cover Wegovy as of 2026. The SELECT trial's cardiovascular outcomes data has strengthened the case for coverage, and many large employers have added Wegovy to their formularies.
For Medicare: Ozempic and Rybelsus are covered for type 2 diabetes under Part D. Wegovy is not covered for weight loss only, but may be covered for cardiovascular risk reduction in eligible patients.
How to Save on Semaglutide: The Complete Playbook
Regardless of which semaglutide product you need, these steps will help you find the lowest price:
-
Identify the right product for your indication. Ozempic or Rybelsus for diabetes; Wegovy for weight management. Using the correct product maximizes your insurance coverage options.
-
Check your insurance formulary. Call member services or log into your insurance portal and ask whether your specific semaglutide product is covered and at what tier.
-
Use the Novo Nordisk Savings Card. Whether you have insurance or not, the savings card is the primary cost-reduction tool. Enroll at ozempic.com or wegovy.com.
-
Order through NovoCare Pharmacy. NovoCare offers the lowest self-pay prices and free home delivery. New patients can pay $199/month for starter doses.
-
Use a prescription discount service. RxGo, GoodRx, and SingleCare can reduce retail pharmacy prices. Always compare before filling.
-
Apply for patient assistance if income-eligible. Novo Nordisk's patient assistance program provides free medication to qualifying patients. Apply at novocare.com/diabetes/help-with-costs/pap.html.
Frequently Asked Questions
Is there a generic semaglutide? No. Semaglutide is a biologic medication protected by patents. Generic versions (biosimilars) are not expected until the early 2030s.
What is the cheapest semaglutide product? Rybelsus (oral tablet) has the lowest list price (~$850/month) among brand-name semaglutide products. For uninsured patients, all three products offer $199/month introductory pricing through NovoCare Pharmacy.
Can I switch between Ozempic and Wegovy? They contain the same active ingredient, but they are different FDA-approved products with different dosing regimens and indications. Switching requires a new prescription and is a clinical decision your doctor should make based on your treatment goals.
Does semaglutide cause cancer? Animal studies showed thyroid tumors in rodents at high doses, which is why semaglutide carries a black box warning about medullary thyroid carcinoma (MTC). Human studies have not demonstrated an increased risk of thyroid cancer. Patients with a personal or family history of MTC or MEN2 syndrome should not use semaglutide.
How does semaglutide work for weight loss? Semaglutide mimics the GLP-1 hormone, which is naturally released after eating. It slows gastric emptying, reduces appetite, and increases feelings of fullness. At the higher doses used in Wegovy, these effects produce an average weight loss of ~15% of body weight over 68 weeks in clinical trials.
Save up to 80% on this medication
Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.
About the Author
RxGuide Editorial Team, PharmD, RPh
Clinical Pharmacist & Medical Writer
The RxGuide editorial team is composed of licensed pharmacists and clinical medical writers with expertise in pharmacology, drug safety, and patient education. All clinical content is reviewed against current FDA labeling, peer-reviewed literature, and established clinical guidelines before publication.
Related Articles
Get the RxGo app — free prescription discounts on the go
Works at 67,000+ pharmacies · No membership needed